Back to search

Article

Estrogen Receptor-negative/progesterone Receptor-positive and Her-2 Negative Breast Cancer Might No Longer Be Classified as Hormone Receptor Positive Breast Cancer

2020-10-05

Abstract excerpt

<title>Abstract</title> <p><bold><italic>Background:</italic> </bold>The estrogen receptor (ER)-negative/progesterone receptor (PR)-positive (sPR positive) phenotype is an infrequent and independent biological entity. However, the prognosis of patients with sPR positive and her-2 negative phenotype is still controversial, and it is not always easy to decide treatment strategies for them.<bold><italic>Methods:</it...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4653bd06-bfe8-53e1-986b-c31adc79cf29
DOI
10.21203/rs.3.rs-73479/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Estrogen Receptor-negative/progesterone Receptor-positive and Her-2 Negative Breast Cancer Might No Longer Be Classified as Hormone Receptor Positive Breast CancerDOI 10.21203/rs.3.rs-73479/v1
Estrogen receptor-negative/progesterone receptor-positive and her-2 negative breast cancer might no longer be classified as hormone receptor positive breast cancerSemantic proximity
Trends in the Incidence and Survival of Women with Hormone Receptor-Positive Breast Cancer from 1990–2019: A Large Population-Based AnalysisSemantic proximity
The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity
Genetic and clinical landscape of ER + /PR- breast cancer in China.Semantic proximity
Risk Evaluation of Early-stage Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Breast Cancer Patients: a Population-based Study From TaiwanSemantic proximity
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updateSemantic proximity
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapySemantic proximity
Adjuvant Chemotherapy Guidance for pT1-3N0-1 Breast Cancer Patients with HR+, HER2- subtype: a study based on SEER databaseSemantic proximity
The loss of progesterone receptor predicts more aggressive biological features and worse outcomes in estrogen receptor-positive and HER2-negative inflammatory breast cancerSemantic proximity
The Value of Oral Selective Estrogen Receptor Degraders in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer after Progression on ≥ 1 Line of Endocrine Therapy: Systematic Review and Meta-analysisSemantic proximity
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of ageSemantic proximity
Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.Semantic proximity
Select a neighboring publication to make it the new centre.